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Objective: There is a possible correlation between endometriosis and an increased risk of epithelial
ovarian cancer (EOC), but many uncertainties remain, including race, exposure or surveillance time, and
surgical conﬁrmation. Therefore, we carried out a large-scale, nationwide, controlled cohort study in the
Taiwanese women to respond to these uncertainties.
Materials and methods: A historical cohort study was performed by linking the National Health Insurance
Research Database of Taiwan. Each patient diagnosed with endometriosis (n ¼ 7537) between 2000 and
2009 was background matched with up to two womenwithout endometriosis (n ¼ 15,074). The total was
136,643 person-years of follow-up and 24 women having new EOC. Cox regression analysis was used to
determine the relationship between the EOC incidence rate and an endometriosis status.
Results: The EOC incidence rate of the endometriosis and non-endometriosis women was 3.31 per
10,000 person-years and 0.99 per 10,000 person-years, respectively, contributing to an adjusted hazard
ratio (HR) of 3.28 (95% conﬁdence interval, 1.37e7.85). The women with surgical conﬁrmation had a
much higher adjusted HR (3.87; 95% conﬁdence interval, 1.58e9.47). No signiﬁcantly statistical difference
of surveillance time between women with and without endometriosis (3.87 years vs. 3.73 years). The
occurrence of EOC was not also affected by exposure time of women with endometriosis.
Conclusion: Taiwanese women with endometriosis really had a risk of newly developed EOC, especially
those who had a surgical diagnosis, and this three-fold increase of risk was neither inﬂuenced by
exposure time nor biased by surveillance.
Copyright © 2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.and Gynecology, Taipei Vet-
rsity, 201, Section 2, Shih-Pai
stitute of Public Health, Na-
reet, Taipei, Taiwan.
o), phwang@vghtpe.gov.tw,
bstetrics & Gynecology. PublishedIntroduction
Endometriosis, affecting 6e10% of women of reproductive age, is
a common gynecological disorder deﬁned by the presence of viable,
extrauterine, endometrial glands, and stroma [1]. It can grow or
bleed cyclically, and possesses several characteristics of invasive
cancer, such as a destructive, invasive, and metastatic nature [2]
that subsequently results in pelvic inﬂammation, adhesion,
chronic pain, and infertility, and progresses to biologic malignant
tumors [3,4]. The relationship between endometriosis andby Elsevier Taiwan LLC. All rights reserved.
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have been proposed initially as early as 1925 by Sampson [5]. A
subsequent study found that cancers arising in endometriosis were
not limited to the ovary. The ovary is the most common site (78.7%)
[6], and endometriosis at the ovary had a higher risk of EOC
compared with the other sites (5% vs. 1%) [7].
Many epidemiologic or molecular studies have indicated that
women with endometriosis may have an increased risk of devel-
oping EOC [8e28]. However, not all studies supported the positive
correlation, thus contributing to many uncertainties. For example,
Olson and colleagues [29] did not ﬁnd any signiﬁcant association
[age-adjusted relative risk 0.8, 95% conﬁdence interval (CI)
0.2e2.4]. Similar results of no association between EOC and
endometriosis were also found in studies analyzing patients at an
infertility clinic or those who had potential exposure to ovarian
inﬂammatory factors [30e32]. By contrast, two Japanese studies
[14,15] reported an especially higher risk of EOC in women with
ultrasound-diagnosed ovarian endometrioma [hazard ratios (HR)
of 8.95 for all EOCs and 13.5 for speciﬁc-type EOCs] than did the
majority of other studies [8e13,16e28]. Therefore, it was necessary
to carry out an extensive literature search before we tried to
conduct the study to investigate the relationship between endo-
metriosis and EOC. We used the term “ovarian cancer risk and
endometriosis” (up to February 26, 2014) to search PubMed for
relevant English-language articles and identiﬁed 278 published
articles. Additional reports identiﬁed from the articles found during
the initial search were reviewed for relevance. We found that
nearly all existing evidence was from the Western populations
[8e13,16e30], except two above-mentioned studies [14,15]. We
analyzed all cohort studies [14,16e18,20,21,27e30], including
133,976 women with endometriosis, and the HR was 1.68 (95% CI
1.52e1.87). The power of the increased risk from this meta-analysis
may not be strong to support causality. In addition, biases might
further weaken this association [33,34]. For example, the age factor,
exposure duration, obstetric and gynecologic history [infertility
status, pelvic inﬂammatory disease (PID), etc.], and Charlson Co-
morbidity Index (CCI) are all confounding factors associated with
either endometriosis or EOC. In fact, not all studies adequately
controlled for these confounders. Furthermore, the basic deﬁnition
of endometriosis varied greatly, from a high possibility of
misclassiﬁcation, such as self-reported endometriosis [29], to a
severe selection bias, such as ovarian endometrioma [14,15], which
might result in an under- or overestimated risk of developing EOC.
Moreover, many authors have used the results (women with
diagnosed EOC) to retrospectively investigate the causal factor
(women with history of endometriosis) [3].
The other question of whether the exposure time or surveillance
affects occurrence of EOC is uncertain. This issue is important,
because it inﬂuences the ﬁnal decision-making in the management
of women with endometriosis. In addition, the answer to ques-
tiondwhether the risk of EOC is also increased in the Taiwanese
population with endometriosisdis unknown, because no study
could be referenced. Therefore, we carried out a large-scale,
nationwide, controlled cohort study in Taiwan to investigate
whether endometriosis womenwith/without surgical conﬁrmation
or the exposure time raises the risk of developing EOC. The ﬁndings
may help physicians make a better assessment of the risks and
beneﬁts associated with surgical management of endometriosis.
Methods
The Taiwanese National Health Insurance (NHI) programwas set
up in 1995. More than 99% of the residents in Taiwan are enrolled in
this program. As of December 2010, it covered >99% of the popu-
lation (23,074,487 beneﬁciaries) and contracted with almost allmedical hospitals and clinics in Taiwan (25,031 institutions) [35].
The NHI program in Taiwan provides a comprehensive coverage for
inpatient and outpatient medical services, including prescription
drugs [1]. The National Health Research Institute cooperated with
the Bureau of NHI in 2000 to establish an NHI Research Database
that would guard the privacy and conﬁdentiality of all beneﬁciaries
and provide health insurance data to researchers who have ob-
tained ethical approval [1]. The Longitudinal Health Insurance
Database 2000 (LHID 2000) contains the entire original enrollment
and claims data of 1 million beneﬁciaries, randomly sampled from
among the beneﬁciaries of the NHI Research Database during the
period 1996 to 2000. The data of the sampled individuals in the
LHID 2000 are representative of all beneﬁciaries with regard to age,
sex, and insurance cost. These data include details of medical or-
ders, procedures, and medical diagnoses with codes based on the
International Classiﬁcation of Diseases, Ninth Revision, Clinical Mod-
iﬁcations (ICD9-CM), and the identity of all patients in the LHID.
This was a retrospective cohort study (approval for the study
was obtained from the local ethics committee; VGHIRB 2012-12-
012BC); 191,858 women aged between 20 years and 51 years were
identiﬁed.Womenwith a diagnosis of EOC, endometriosis or with a
total hysterectomy prior to their diagnosis of endometriosis, and
without a visit to an obstetrician or gynecologist during the study
period were excluded. To increase the identiﬁcation validity of the
women with endometriosis in the administrative data set, only
those women with three or more visits and with a primary diag-
nosis of endometriosis within 1 year or with one surgically
conﬁrmed diagnosis of endometriosis during the period between
January 1, 2000, and December 31, 2009 were referred to as women
with endometriosis, the exposure group (n ¼ 7537).
Each woman in the exposure group was matched with two
women in the remaining sample by age, index year, obstetric his-
tory, socioeconomic status, work, and urbanization (Fig. 1), because
many of these factors were reported to be correlated with the
occurrence of invasive EOC [8e10,12,13,16,21e25,30]. The matched
women without endometriosis were referred to as the non-
exposure group (n¼ 15,074). For the exposure group, the index date
was the date of the ﬁrst visit/admission between 2000 and 2009
that resulted in a diagnosis code for endometriosis (ICD9-CM code
617.0e617.9). For the nonexposure group, the index date was the
ﬁrst visit/admission to an obstetric/gynecological provider during
the study period.
Invasive EOC was initially detected in inpatients with a surgi-
copathological diagnosis and validated using the major disease ﬁles
(ICD-9-CM 183.0 from the Registry for Catastrophic Illness Pa-
tients). Because synchronous endometriosis and EOC is commonly
found and the prevalence of endometriosis in invasive EOC may
vary in different subtypes of EOC [e.g., clear cell (35e39%), endo-
metrioid (21e27%), serous (3e5%), and mucinous type (3e4%)]
[36]dand to clarify the subsequent risk of developing EOC in
women with endometriosisdwe excluded patients with synchro-
nous endometriosis and EOC. Furthermore, we also excluded those
women with a diagnosis of EOC within 1 year after their ﬁrst
diagnosis of endometriosis or the ﬁrst visit/admission to an ob-
stetric/gynecological provider.
Statistical analysis
Starting from the cohort index date, the study participants were
followed until the occurrence of hospitalization with EOC (ICD-9-
CM 183.0) or death, whichever came ﬁrst, or to the end of the
study (December 31, 2010) if no EOC or death had occurred. Basic
characteristics are presented as a percentage. The incidence of EOC
was compared between the women with and without endometri-
osis using the incidence rate (IR). The Cox proportional hazards
Fig. 1. Cohort ﬂow chart illustrating the inclusion and exclusion of participants in the study.
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whether newly diagnosed endometriosis is a risk factor for the
development of EOC. The adjusted variables in the model were PID,
infertility status, cardiovascular (CV) disease, diabetes mellitus,
chronic liver disease, rheumatic disease, and CCI. Differences in the
interval between enrollment in each cohort and the diagnosis of
EOCwere evaluated via theManneWhitney or KruskaleWallis test.
This study used the SAS statistical package, version 9.3 (SAS Insti-
tute, Cary, NC, USA), RevMan5, version 5.02 (Cochrane IMS,
Copenhagen, Denmark), and SPSS version 20 (SPSS Inc., Chicago, IL,
USA) to perform statistical analyses.
Results
Of the total of 22,611 participants, 24 developed invasive EOC
between 2001 and 2010. The total person-years of follow-up were
136,643, including 45,364 for women with newly diagnosed
endometriosis and 91,279 for the nonendometriosis women.
Characteristics at baseline are shown in Table 1. Womenwith newly
diagnosed endometriosis had higher rates of comorbid PID, infer-
tility status, CV disease, diabetes mellitus, chronic liver disease,
rheumatic disease, and CCI than did womenwithout endometriosis
(all p < 0.0001).
The EOC IR of the women with endometriosis and the non-
endometriosis women were 3.31 per 10,000 person-years and 0.99
per 10,000 person-years, respectively, contributing to a crude HR of
3.35 (95% CI 1.47e7.66). After adjusting for confounders, the
adjusted HR was 3.28 (95% CI 1.37e7.85; Table 2). Of the 7537
women with endometriosis, 5468 had a surgical conﬁrmation and
the remaining 2069 did not (Table 3). The EOC IR of the women
with endometriosis with surgical conﬁrmationwas 3.91 per 10,000
person-years, contributing to signiﬁcantly higher adjusted HR forEOC than the nonendometriosis women (HR 3.87, 95% CI
1.58e9.47). No signiﬁcant difference was found between endome-
triosis women without surgical conﬁrmation and non-
endometriosis (Table 3).
Finally, to evaluate the duration before the patients in this
cohort would develop an EOC, the time interval between enroll-
ment in each cohort and the diagnosis of newly developing EOC
(exposure time or surveillance time) was calculated. The median
time for all women with EOC was 3.80 (range 1.13e9.40) years
(Table 4). The median time of the women with endometriosis,
regardless of surgical conﬁrmation status, was 3.87 (range
1.29e9.40) years, compared with 3.73 years in the non-
endometriosis women. There was no statistically signiﬁcant dif-
ference in median age or median time interval among all groups
(Table 4). HR was also not affected by exposure time inwomenwith
endometriosis (data not shown).
Taken together, these data suggested that Taiwanese women
with endometriosis really had a risk of newly developed EOC, and
this risk was much higher in those women with surgically
conﬁrmed endometriosis; however, the increased risk did not seem
to be inﬂuenced by exposure time or biased by surveillance.
Discussion
Our data suggest that after adjusting for the main potential
confounding factors (age, socioeconomic status, work, urbaniza-
tion, PID, infertility status, CV disease, diabetes mellitus, chronic
liver disease, rheumatic disease, and CCI), the risk of developing
invasive EOC in women with endometriosis was almost three-fold
that in women without endometriosis. In this study, we also
found that the association between endometriosis and subse-
quently developing EOC varied by surgical conﬁrmation. The HR
Table 1
Baseline characteristics of study participants.
Total (n ¼ 22,611) Endometrioses (n ¼ 7537) Controls (n ¼ 15,074) p
Person-years 136,643 45,364 91,279
Variable n % n % n %
Catastrophic illness 0.0024*
EOC 24 0.11 15 0.20 9 0.06
No EOC 22,587 99.89 7522 99.80 15,065 99.94
Age (y)a 0.0792
20e29 2810 12.43 929 12.33 1881 12.48
30e39 7114 31.46 2384 31.63 4730 31.38
40e49 10,530 46.57 3557 47.19 6973 46.26
50e51 2157 9.54 667 8.85 1490 9.88
SES 0.9271
40,000 3428 15.16 1153 15.30 2275 15.09
20,000e39,999 7075 31.29 2358 31.29 4717 31.29
<20,000 8105 35.85 2708 35.93 5397 35.80
Others 4003 17.70 1318 17.49 2685 17.81
Work 0.6596
Yes 20,866 92.28 6947 92.17 13,919 92.34
No 1745 7.72 590 7.83 1155 7.66
Urbanization 0.8259
Urban 8186 36.20 2722 36.12 5464 36.25
Suburban 10,458 46.25 3476 46.12 6982 46.32
Rural 3967 17.54 1339 17.77 2628 17.43
PID <0.0001**
Yes 11,726 51.86 5713 75.80 6013 39.89
No 10,885 48.14 1824 24.20 9061 60.11
Infertility <0.0001**
Yes 1158 5.12 844 11.20 314 2.08
No 21,453 94.88 6693 88.80 14,760 97.92
CV disease <0.0001**
Yes 852 3.77 362 4.80 490 3.25
No 21,759 96.23 7175 95.20 14,584 96.75
Diabetes mellitus <0.0001**
Yes 1324 5.86 550 7.30 774 5.13
No 21,287 94.14 6987 92.70 14,300 94.87
Chronic liver disease <0.0001**
Yes 355 1.57 153 2.03 202 1.34
No 22,256 98.43 7384 97.97 14,872 98.66
Rheumatic disease <0.0001**
Yes 667 2.95 296 3.93 371 2.46
No 21,944 97.05 7241 96.07 14,703 97.54
CCI <0.0001**
0 15,244 67.42 4445 58.98 10,799 71.64
1 4549 20.12 1824 24.20 2725 18.08
2 1697 7.51 748 9.92 949 6.30
3 1121 4.96 520 6.90 601 3.99
*p < 0.01.
**p < 0.001.
CCI ¼ Charlson Comorbidity Index; CV disease ¼ cardiovascular disease; EOC ¼ invasive epithelial ovarian cancer; SES ¼ socioeconomic status; PID ¼ pelvic inﬂammatory
disease.
a Age is matched by a deﬁnite year of age (e.g., 21 years vs. 21 years), not by range of years of age (e.g., 20e29 years vs. 20e29 years).
Table 2
Incidence and crude and adjusted risk of invasive epithelial ovarian cancer, ac-
cording to endometriosis status.a
Patients with
endometriosis
(n ¼ 7537)
Controls
(n ¼ 15,074)
Number of patients with EOC 15 9
Incidence per 10,000 person-years 3.31 0.99
Crude HR (95% CI) 3.35 (1.47e7.66)* 1.00
Adjusted HR (95% CI) 3.28 (1.37e7.85)* 1.00
*p < 0.01.
CI ¼ conﬁdence interval; EOC ¼ invasive epithelial ovarian cancer; HR ¼ hazard
ratio.
a Adjusted for age, socioeconomic status, work, urbanization, pelvic inﬂammatory
disease, infertility status, cardiovascular disease, diabetes mellitus, chronic liver
disease, rheumatic disease, and Charlson Comorbidity Index.
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endometriosis. Of most importance, the median age and median
time between the enrollment and occurrence of EOC were also
similar among the groups, without showing signiﬁcant statistical
difference. To the best of our knowledge, this was the ﬁrst
nationwide, population-based cohort study for Taiwanese women.
We not only assessed the relationship between endometriosis and
subsequently developing EOC, but also explored the surgical
conﬁrmation status of women with endometriosis and the expo-
sure and surveillance time in this relationship.
The strength of this study included the following factors. First,
the criteria for a diagnosis of endometriosis varied dramatically [37],
which may have directly inﬂuenced the estimated association be-
tween endometriosis and EOC. In this study, this critical misclassi-
ﬁcation bias was assessed. The diagnosis of endometriosis was
made by gynecologists using relatively strict criteria [outpatients
who received ≥3 diagnoses of endometriosis (ICD code) within
Table 3
Incidence and crude and adjusted risk of invasive epithelial ovarian cancer, ac-
cording to endometriosis with/without surgical conﬁrmation status.a
Patients with endometriosis Controls
(n ¼ 15,074)
Surgical
conﬁrmation
No surgical
conﬁrmation
(n ¼ 5468) (n ¼ 2069)
Number of patients
with EOC
13 2 9
Incidence per 10,000
person-years
3.91 1.66 0.99
Crude HR (95% CI) 3.96 (1.69e9.26)* 1.68 (0.36e7.78) 1.00
Adjusted HR (95% CI) 3.87 (1.58e9.47)* 1.64 (0.35e7.80) 1.00
*p < 0.01.
CI ¼ conﬁdence interval; EOC ¼ invasive epithelial ovarian cancer; HR ¼ hazard
ratio.
a Adjusted for age, socioeconomic status, work, urbanization, pelvic inﬂammatory
disease, infertility status, cardiovascular disease, diabetes mellitus, chronic liver
disease, rheumatic disease, and Charlson Comorbidity Index.
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[1]. In addition, 72.5% of all women with endometriosis in this
cohort study had a surgical conﬁrmation. Compared with partici-
pant's self-report [29], misclassiﬁcation bias might be small. The
main results indicate that women with surgically conﬁrmed endo-
metriosis had a signiﬁcantly higher EOC risk (adjustedHR3.87) than
women without endometriosis. This adjusted HR result was higher
than the one obtained by deﬁning the exposure group as those
womenwith an endometriosis diagnosis, regardless of their surgical
conﬁrmation status; and much higher than the adjusted HR (1.64)
obtained by deﬁning the exposure group as those women without
surgical conﬁrmation. Our results indicated that differences in
criteria for deﬁning endometriosis might inﬂuence the ﬁndings.
Broader criteria, such as the self-reported endometriosis commonly
used inprevious studies,may lead to an underestimation of EOC risk
among women with endometriosis [29,38,39].
By contrast, if the patients with endometriosis were limited to
those women who had ovarian endometrioma, for example, as
shown above [14,15], the risk might be overestimated (HR ¼ 8.95
and HR ¼ 13.5, respectively). In addition, it might not really reﬂect
the risk of developing EOC in “endometriosis”women, because one
study showed that 30.9% (100/324) of women with endometriosis
had peritoneal implants only, without ovarian involvement [40].
Second, in this study, many factors such as nulliparity and
infertility were well controlled (Fig. 1), because some reports
claimed that nulliparity and infertility were risk factors forTable 4
Age and interval between enrollment in the cohort and the diagnosis of newly develope
Total (n ¼ 24) Endome
Age (y)
Mean ± SD 42.0 ± 5.9 41.6 ± 5
Median (range) 44.5 (26e50) 44.0 (32
Interval (d)
Mean ± SD 1402.8 ± 789.9 1463.3 ±
Median (range) 1389 (414e3433) 1414 (47
Endometriosis (n ¼ 15)
Surgical conﬁrmation
(n ¼ 13)
No sur
(n ¼ 2)
Age (y)
Mean ± SD 41.7 ± 5.4 41.0 ±
Median (range) 44.0 (32e50) 41.0 (2
Interval (d)
Mean ± SD 1472.4 ± 893.7 1404.5
Median (range) 1414 (471e3433) 1404.5
Age¼ age at the diagnosis of newly developing invasive epithelial ovarian cancer; Interva
invasive epithelial ovarian cancer.developing EOC, and by contrast, hysterectomy and tubal ligation
were protective [27]. Not all studies adequately controlled for these
confounders [33,34]. Our study ﬁndings provide another support-
ing evidence on the possible causality relationship between
endometriosis and EOC.
Third, in this study, we evaluated the difference of the median
age and exposure or surveillance time between endometriosis and
nonendometriosis, because the risk of developing EOC in women
with endometriosis might vary by age or follow-up time. Kobayashi
et al's study [14] found that the risk increased as the age of ovarian
endometrioma diagnosis increased, with a standardized IR ¼ 13.2
(95% CI 6.90e20.9) inwomen older than 50 years. However, the risk
did not increase with increasing follow-up duration [14]. By
contrast, Melin and colleagues [16] reported that women with
long-standing endometriosis that had been diagnosed early had a
higher risk of EOC, with a standardized IR ¼ 2.01 and IR ¼ 2.23,
respectively. That a long-standing history of ovarian endometrioma
contributes to a particularly elevated risk of EOC was also sup-
ported by Brinton et al's study [21]. However, in our current study,
we did not ﬁnd the difference of median age, exposure time, and
surveillance between the exposure and nonexposure groups, sug-
gesting that the increased risk of EOC in the women with endo-
metriosis was neither inﬂuenced by exposure time nor biased by
surveillance.
Fourth, in our current study, the yearly incidence of all types of
EOC in nonendometriosis women was 9.9 per 100,000 women,
which was very similar to that of the general population (7.3 per
100,000 women at any age and 15.6 per 100,000 women aged
between 50 years and 54 years) [41].
Only a small number of tumors developed during the follow-up
period, limiting the precision of our risk estimates in our study.
However, compared with a previous study with a large sample size
[26], only 10 cases of EOC was observed during a 5e9-year follow-
up or the observed EOC cases were 14 during a ~6-year follow-up,
suggesting that the risk was indeed high in our current study. Also,
our ability to examine the relation between the risk of developing
EOC and speciﬁc types of medical treatment, and between the
endometriosis and histologic subtypes of EOC, was limited. The
similar surveillance interval between enrollment in the cohort and
the diagnosis of EOC among all groups, and the exclusion of those
participants with a diagnosis of EOC within 1 year before or after a
new diagnosis of endometriosis, suggest that the observed increase
in risk was not due to the diagnosis of preexisting tumors. By
contrast, it is possible that the most aggressive EOC cases might
have been excluded in the study.d invasive epithelial ovarian cancer.
trioses (n ¼ 15) Controls (n ¼ 9) p
.2 42.8 ± 7.2
e50) 45.0 (26e50) 0.417
885.9 1301.9 ± 634.1
1e3433) 1364 (414e2168) 0.743
Controls (n ¼ 9) p
gical conﬁrmation
5.7 42.8 ± 7.2
6e50) 45.0 (26e50) 0.689
± 1181.6 1301.9 ± 634.1
(569e2240) 1364 (414e2168) 0.939
l¼ interval between enrollment in the cohort and the diagnosis of newly developing
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serious concern [42], especially with the high prevalence rate of
endometriosis and the low prevalence rate of EOC. However, the
judgment of risk stratiﬁcation algorithms might not be easy [43],
even though we found that Taiwanese womenwith endometriosis,
especially those who had a surgical conﬁrmation, had a signiﬁ-
cantly higher risk of newly developed EOC, and this increased risk
was neither inﬂuenced by exposure time nor biased by surveil-
lance.We suggested that the risk/beneﬁt ratio be balanced carefully
[44], because this increased risk not only relies on howwell we help
with disease detection (new developed EOC) when present, but
also depends on how accurately we protect patients from the
danger of a false-positive result (endometriosis).
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